These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24515299)

  • 1. Management of hypovitaminosis D in patients with primary hyperparathyroidism.
    Rathi MS; Gonzalez S; Wright D; Ellis NR; Peacey SR
    J Endocrinol Invest; 2014 May; 37(5):467-71. PubMed ID: 24515299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose cholecalciferol supplementation and dual vitamin D therapy in haemodialysis patients.
    Dusilová-Sulková S; Šafránek R; Vávrová J; Horáček J; Pavlíková L; Palička V
    Int Urol Nephrol; 2015 Jan; 47(1):169-76. PubMed ID: 25262147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial.
    Alvarez JA; Law J; Coakley KE; Zughaier SM; Hao L; Shahid Salles K; Wasse H; Gutiérrez OM; Ziegler TR; Tangpricha V
    Am J Clin Nutr; 2012 Sep; 96(3):672-9. PubMed ID: 22854402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of 25-hydroxy vitamin D response at short (2 month) and long (1 year) interval after 8 weeks of oral supplementation with cholecalciferol in Asian Indians with chronic hypovitaminosis D.
    Goswami R; Gupta N; Ray D; Singh N; Tomar N
    Br J Nutr; 2008 Sep; 100(3):526-9. PubMed ID: 18252022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency.
    Grey A; Lucas J; Horne A; Gamble G; Davidson JS; Reid IR
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2122-6. PubMed ID: 15644400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism.
    Bucharles S; Barberato SH; Stinghen AEM; Gruber B; Piekala L; Dambiski AC; Custodio MR; Pecoits-Filho R
    J Ren Nutr; 2012 Mar; 22(2):284-291. PubMed ID: 21908203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D3 supplementation in healthy adults: a comparison between capsule and oral spray solution as a method of delivery in a wintertime, randomised, open-label, cross-over study.
    Todd JJ; McSorley EM; Pourshahidi LK; Madigan SM; Laird E; Healy M; Magee PJ
    Br J Nutr; 2016 Oct; 116(8):1402-1408. PubMed ID: 27724992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis.
    Sahota O; Mundey MK; San P; Godber IM; Lawson N; Hosking DJ
    Bone; 2004 Jul; 35(1):312-9. PubMed ID: 15207772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data.
    Diamond TH; Ho KW; Rohl PG; Meerkin M
    Med J Aust; 2005 Jul; 183(1):10-2. PubMed ID: 15992330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.
    Lips P; Duong T; Oleksik A; Black D; Cummings S; Cox D; Nickelsen T
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1212-21. PubMed ID: 11238511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of vitamin D replacement in patients with normocalcaemic and hypercalcaemic primary hyperparathyroidism and coexisting vitamin D deficiency.
    Das G; Eligar V; Govindan J; Bondugulapati LN; Okosieme O; Davies S
    Ann Clin Biochem; 2015 Jul; 52(Pt 4):462-9. PubMed ID: 25468998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity in serum 25-hydroxy-vitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency.
    Giusti A; Barone A; Pioli G; Girasole G; Razzano M; Pizzonia M; Pedrazzoni M; Palummeri E; Bianchi G
    J Am Geriatr Soc; 2010 Aug; 58(8):1489-95. PubMed ID: 20646099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe hypercalcaemia following vitamin D replacement for tuberculosis-associated hypovitaminosis D.
    Lavender TW; Martineau AR; Quinton R; Schwab U
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):140. PubMed ID: 22236861
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of 25-hydroxyvitamin D deficiency on perioperative parathyroid hormone kinetics and results in patients with primary hyperparathyroidism.
    Untch BR; Barfield ME; Dar M; Dixit D; Leight GS; Olson JA
    Surgery; 2007 Dec; 142(6):1022-6. PubMed ID: 18063090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D.
    Tucci JR
    Eur J Endocrinol; 2009 Jul; 161(1):189-93. PubMed ID: 19383807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral cholecalciferol 2,000 versus 5,000 IU on serum vitamin D, PTH, bone and muscle strength in patients with vitamin D deficiency.
    Diamond T; Wong YK; Golombick T
    Osteoporos Int; 2013 Mar; 24(3):1101-5. PubMed ID: 22422304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D and primary hyperparathyroidism (PHPT).
    Souberbielle JC; Bienaimé F; Cavalier E; Cormier C
    Ann Endocrinol (Paris); 2012 Jun; 73(3):165-9. PubMed ID: 22677209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low vitamin D levels have become less common in primary hyperparathyroidism.
    Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Bilezikian JP; Silverberg SJ
    Osteoporos Int; 2015 Dec; 26(12):2837-43. PubMed ID: 26084258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial.
    Wetmore JB; Kimber C; Mahnken JD; Stubbs JR
    Br J Nutr; 2016 Dec; 116(12):2074-2081. PubMed ID: 28065190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosing hypovitaminosis D: serum measurements of calcium, phosphate, and alkaline phosphatase are unreliable, even in the presence of secondary hyperparathyroidism.
    Smith GR; Collinson PO; Kiely PD
    J Rheumatol; 2005 Apr; 32(4):684-9. PubMed ID: 15801026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.